×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Market Access, Medical Affairs, and Regulatory Affairs Functions Working Together to Address Payor and Regulatory Requirements
Session Chair(s)
Todd Paporello, PharmD, MBA
Vice President, Global Head of Regulatory Affairs, Specialty Care
Sanofi, United States
Drug development is evolving to address payor and regulatory requirements. Market access, medical affairs, and regulatory affairs functions are working together in this complex payor and regulatory ecosystem to sustain patient access to medicine.
Learning Objective : Summarize how the market access, medical affairs, and Regulatory Affairs functions within a pharmaceutical company are working together differently now then they have in the past to address both payor and regulatory requirements; Name the ways the drug development is evolving to ensure clinical trials are addressing coverage and regulatory decisions.
Speaker(s)
Industry Perspective
I-Fen Chang, PharmD
Amgen, United States
Vice President, Head of Oncology Global Medical
Industry Perspective
Todd Paporello, PharmD, MBA
Sanofi, United States
Vice President, Global Head of Regulatory Affairs, Specialty Care
Industry Perspective
Cindy McDonald-Everett
Seagen, United States
Senior Vice President, Global Value Access
Have an account?